Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Inflation Reduction Act
Pharma
BMS leans on long-term growth drivers to dodge IRA impacts
Facing pressure from the IRA and falling sales for Abecma, BMS CEO Chris Boerner says the Beyenzi-maker had a "good start" with the first quarter.
Zoey Becker
Apr 25, 2024 12:57pm
The best returns come from small M&A deals: McKinsey report
Apr 9, 2024 10:45am
HHS responds to Big Pharma's IRA counteroffers
Apr 3, 2024 11:18am
GLP-1 sales surge to power industry earnings growth: Moody's
Mar 15, 2024 9:50am
PhRMA seeks to revive IRA lawsuit, blasts Biden's SOTU update
Mar 8, 2024 8:57am
GSK's asthma inhaler market pull draws Warren's ire
Mar 5, 2024 10:57am